HHS ramps up drug pricing efforts with another proposed rule sent for review
Source: SeekingAlpha
2025-10-04 12:15:34 ET
More on Pfizer, VanEck Pharmaceutical ETF, etc.
- Merck: A Race Against The Keytruda Clock
- PPH: The Big Pharma ETF
- Pfizer: The Long Suffering Is Finally Over (Rating Upgrade)
- Pfizer – TrumpRx deal boosts Big Pharma to a record rally
- Notable analyst calls this week: J&J, PayPal and Corteva among top picks
Read the full article on Seeking Alpha
For further details see:
HHS ramps up drug pricing efforts with another proposed rule sent for review
Harte-Hanks, Inc.
NASDAQ: HHS
HHS Trading
-3.35% G/L:
$2.66 Last:
1,485 Volume:
$2.66 Open:
HHS Latest News
October 21, 2025 05:05:00 pm
Harte Hanks Partners with Samsung to Open Dedicated Customer Care Center in Greenville, SC; Supporting 150+ Jobs
HHS Stock Data
$21,577,051
5,405,385
0.75%
12
N/A
Industrial Conglomerates
Industrials
US
Chelmsford
